Year in Review: HIV
Long-acting therapies headlined a year of continued drug development, both in the treatment and prevention of HIV. Meanwhile, CDC recommended a third dose of a COVID-19 mRNA vaccine for certain patients living with advanced or untreated HIV to boost their protection. Cabotegravir’s Big Year The year started with the approval of cabotegravir-rilpivirine (Cabenuva), the first […]
9/11 Responders Face Higher Risk of Multiple Cancers
Ongoing research funded by the World Trade Center (WTC) Health Program has continued to show associations between exposures to the WTC site after the terrorist attacks on Sept. 11, 2001 and various cancers, as evidenced by two studies recently published in Occupational & Environmental Medicine. According to the first study, male New York City firefighters […]